Mesoblast Limited
Status: Publicly traded
Direct answer
Mesoblast Limited is publicly traded on ASX under the ticker MSB.AX.
Mesoblast Limited, an Australian enterprise established in Melbourne in 2004, is dedicated to developing innovative regenerative medicine products. The company's global reach extends to the United States, Singapore, the United Kingdom, and Switzerland. Its therapeutic endeavors encompass a wide array of medical conditions, including cardiovascular diseases, spinal and orthopedic ailments, oncology, hematology, and...
Can you invest in Mesoblast Limited?
Yes. Mesoblast Limited is publicly traded on ASX under the ticker MSB.AX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Mesoblast Limited
Detailed equity research is provided by MarketSnap.